ITRM stock as FDA agrees to Phase 3 trial for UTI candidate (NASDAQ:ITRM)
The shares of clinical-stage pharma Iterum Therapeutics (ITRM) jumped ~64% in the morning hours Monday after the company announced an agreement with the FDA over the design of a Phase…
ITRM stock as FDA agrees to Phase 3 trial for UTI candidate (NASDAQ:ITRM)
The shares of clinical-stage pharma Iterum Therapeutics (ITRM) jumped ~64% in the morning hours Monday after the company announced an agreement with the FDA over the design of a Phase…